Advertisement

Picture [iito] No Tracking 650x80px
Organisation › Details

Catalent Inc. (NYSE: CTLT)

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal year 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com. Catalent Biologics provides advanced technologies and integrated solutions for biologic and biosimilar development and manufacturing, from DNA to fill/finish and commercial supply, through its extensive Biologics network including: Bloomington, Indiana, where the company recently announced a twentieth commercial launch of a fill/finish product, and Madison, Wisconsin, home of Catalent Biologics’ proprietary GPEx® technology for stable, high-yielding mammalian cell lines with eleven approved molecules. *

 

Period Start 2019-04-15 existent
  Group Catalent (Group)
Products Industry contract manufacturing (drugs)
  Industry 2 drug delivery technology (drug formulation technology)
Person Person Chiminski, John (Catalent 201904 CEO)
     
  Street 14 Schoolhouse Road
  City 08873 Somerset, NJ
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Catalent, Inc.. (4/15/19). "Press Release: Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion". Somerset, NJ & Baltimore, MD.
     
   
Record changed: 2020-09-21

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Catalent (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81




» top